Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Leukemia |
Free Subscription
1 Acta Haematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
Failure of treatment-free remission after a prolonged deep molecular response in
patients with chronic myeloid leukemia.
Acta Haematol. 2024 Apr 4. doi: 10.1159/000538651.
PubMed
Abstract available
Bendamustine, followed by obinutuzumab and idelalisib in chronic lymphocytic
leukemia (CLL2-BCG): Final analysis of a multicenter, open-label phase-II-trial.
Am J Hematol. 2024 Apr 5. doi: 10.1002/ajh.27304.
PubMed
Redefining hyperviscosity in acute leukemia: Potential implications for red cell
transfusions in the microvasculature.
Am J Hematol. 2024 Apr 4. doi: 10.1002/ajh.27308.
PubMed
Abstract available
Pre-B acute lymphoblastic leukemia presenting with NPM1 and FLT3 mutations.
Am J Hematol. 2024 Apr 3. doi: 10.1002/ajh.27301.
PubMed
Hepatotoxicity as dose-limiting toxicity of the combination of bosutinib and
atezolizumab in patients with chronic myeloid leukemia. Results of the ZEROLMC
study.
Ann Hematol. 2024 Apr 3. doi: 10.1007/s00277-024-05662.
PubMed
Abstract available
Gilteritinib combined with venetoclax and azacitidine for relapsed acute myeloid
leukemia cocurrent with pure red cell aplasia after allogeneic hematopoietic stem
cell transplantation: a case report.
Ann Hematol. 2024 Apr 1. doi: 10.1007/s00277-024-05714.
PubMed
Abstract available
Targeting PD-L1 to treat ATLL?
Blood. 2024;143:1320-1322.
PubMed
How I reduce and treat posttransplant relapse of MDS.
Blood. 2024;143:1344-1354.
PubMed
Abstract available
Developmental trajectories and cooperating genomic events define molecular
subtypes of BCR::ABL1-positive ALL.
Blood. 2024;143:1391-1398.
PubMed
Abstract available
Non-canonical transcriptional regulation of the poor prognostic factor UGT2B17 in
chronic lymphocytic leukemic and normal B cells.
BMC Cancer. 2024;24:410.
PubMed
Abstract available
Allogeneic hematopoietic cell transplantation for older patients with AML with
active disease. A study from the Acute Leukemia Working Party of the European
Society for Blood and Marrow Transplantation (EBMT).
Bone Marrow Transplant. 2024 Mar 30. doi: 10.1038/s41409-024-02275.
PubMed
Abstract available
Curing pediatric cancer: A global view. Examples from acute lymphoblastic
leukemia.
Cancer. 2024 Mar 29. doi: 10.1002/cncr.35290.
PubMed
Impact of tocilizumab on anti-CD19 chimeric antigen receptor T-cell therapy in
B-cell acute lymphoblastic leukemia.
Cancer. 2024 Apr 5. doi: 10.1002/cncr.35316.
PubMed
Abstract available
Targeting Metabolic Dependencies Fueling the TCA Cycle to Circumvent Therapy
Resistance in Acute Myeloid Leukemia.
Cancer Res. 2024;84:950-952.
PubMed
Abstract available
Pivotal role of dihydroorotate dehydrogenase as a therapeutic target in adult
T-cell leukemia.
Eur J Haematol. 2024 Apr 1. doi: 10.1111/ejh.14209.
PubMed
Abstract available
The CNS microenvironment promotes leukemia cell survival by disrupting tumor
suppression and cell cycle regulation in pediatric T-cell acute lymphoblastic
leukemia.
Exp Cell Res. 2024 Mar 30:114015. doi: 10.1016/j.yexcr.2024.114015.
PubMed
Abstract available
The critical role of the bone marrow stromal microenvironment for development of
drug screening platforms in leukemia.
Exp Hematol. 2024 Mar 27:104212. doi: 10.1016/j.exphem.2024.104212.
PubMed
Abstract available
Tumor lysis syndrome in induction therapy for acute myeloid leukemia before the
rasburicase era.
Int J Hematol. 2024 Apr 5. doi: 10.1007/s12185-024-03752.
PubMed
Abstract available
Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T
Cell-Mediated Cytotoxicity.
J Immunol. 2024;212:1381-1391.
PubMed
Abstract available
Mathematical modelling of clonal reduction therapeutic strategies in acute
myeloid leukemia.
Leuk Res. 2024;140:107485.
PubMed
Abstract available
Clinical validation of a 10-color flow cytometry panel to detect measurable
residual disease in acute myeloid leukemia.
Leuk Res. 2024;140:107482.
PubMed
IkappaBepsilon deficiency accelerates disease development in chronic lymphocytic leukemia.
Leukemia. 2024 Apr 4. doi: 10.1038/s41375-024-02236.
PubMed
Abstract available
A complex interplay of intra- and extracellular factors regulates the outcome of
fetal- and adult-derived MLL-rearranged leukemia.
Leukemia. 2024 Mar 30. doi: 10.1038/s41375-024-02235.
PubMed
Abstract available
Retraction: Sensitive Detection of Pre-Existing BCR-ABL Kinase Domain Mutations
in CD34+ Cells of Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients
Is Associated with Imatinib Resistance: Implications in the Post-Imatinib Era.
PLoS One. 2024;19:e0301946.
PubMed
RIO-kinase 2 is essential for hematopoiesis.
PLoS One. 2024;19:e0300623.
PubMed
Abstract available
Thank you for your interest in scientific medicine.